Individuals with HIV who were resistant to all four antiretroviral drug classes experienced higher mortality than those who were not resistant, a difference primarily due to lower CD4 cell counts.

HIV-1 reverse transcriptase inhibitors remain a cornerstone of antiretroviral therapy, targeting the enzyme responsible for converting viral RNA into DNA. This class of drugs, particularly nucleoside ...

In the hunt for a remedy, when the baton is passed from dedicated academic scientists to an innovative company to trusted community advocates, outcomes for society can be especially powerful. Today, ...

Add Yahoo as a preferred source to see more of our stories on Google. The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday ...

A therapy originally developed for HIV now provides new options for patients with rare genetic disorders. It’s now possible to use these drugs to address DNA defects and enhance muscle function. This ...

Global health is evolving rapidly, with breakthroughs turning into medicine. The latest advancement in viral research is ...

Forbes contributors publish independent expert analyses and insights. Dr. Omer Awan is a practicing physician who covers public health. A twice-yearly injection of a drug known as lenacapavir offered ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...

The Food and Drug Administration has approved a highly effective new HIV-prevention medication, Gilead Sciences reported Wednesday. In clinical trials, the drug nearly eliminated HIV’s spread among ...